General Renal Cancer

Partial Nephrectomy is Associated with Improved Survival in Early Stage Kidney Cancer (04-27-2012)

Patients with early stage kidney cancer who had only the tumor removed experienced better survival rates than those who had the entire kidney removed, according to the results of a study published in the Journal of the American Medical Association.[1] Nearly... Continue Reading

Tivozanib Promising for Metastatic Renal Cell Carcinoma (04-23-2012)

Tivozanib (AV-951) was well tolerated and improved median progression-free survival (PFS) in some patients with advanced renal cell carcinoma (RCC), according to the results of a phase II study published in the Journal of Clinical Oncology. More than... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (03-26-2012)

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading

Targeted Drugs Produce Complete Responses in Some Patients with Metastatic Kidney Cancer (02-28-2012)

Some patients with metastatic kidney cancer experience a complete response (a complete disappearance of detectable cancer) after treatment with Sutent® (sunitinib) or Nexavar® (sorafenib), but researchers have not yet been able to predict which patients... Continue Reading

Lynch Syndrome Also Linked with Breast and Pancreatic Cancer (02-17-2012)

A study of families with Lynch Syndrome has expanded the list of cancers related to the condition: carriers of a Lynch Syndrome gene mutation also appear to have an increased risk of breast cancer and pancreatic cancer. These results were published in... Continue Reading

Inlyta Approved for Advanced Kidney Cancer (01-31-2012)

The US Food and Drug Administration has approved Inlyta® (axitinib) for the treatment of advanced renal cell (kidney) cancer that has not responded to another drug used for this condition. Inlyta is a drug that is taken orally, as a pill. It works by... Continue Reading

Organ Transplant Recipients Have Increased Cancer Risk (11-9-2011)

People who have received a solid organ transplant (such as a kidney or liver) are twice as likely as people in the general population to develop cancer. These results were published in the Journal of the American Medical Association. In 2010, more than... Continue Reading

Regular Use of Nonaspirin NSAIDs May Increase Kidney Cancer Risk (09-20-2011)

Long-term users of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) may have an increased risk of developing renal cell (kidney) cancer. These findings were recently reported in the Archives of Internal Medicine. Nonsteroidal anti-inflammatory... Continue Reading

Greater Cancer Risk Among Taller Women (07-28-2011)

Taller women may have an increased risk of developing certain cancers. Overall, cancer risk increases by 16% for every 4-inch increase in height. These findings were recently reported in Lancet Oncology. Greater insight into height and cancer risk may... Continue Reading

Stay on Top of Your Family History of Cancer (07-15-2011)

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s important to update this information periodically... Continue Reading

« Previous PageNext Page »